Eric Rovner to Prospective Studies
This is a "connection" page, showing publications Eric Rovner has written about Prospective Studies.
Connection Strength
0.627
-
One-year results with selective bladder denervation in women with refractory overactive bladder. Neurourol Urodyn. 2019 11; 38(8):2178-2184.
Score: 0.101
-
Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence. J Urol. 2019 05; 201(5):967-972.
Score: 0.099
-
A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodology. Contemp Clin Trials. 2018 07; 70:83-87.
Score: 0.093
-
Three-month primary efficacy data for the SUCCESS Trial; a phase III, multi-center, prospective, randomized, controlled study treating female stress urinary incontinence with the vesair intravesical balloon. Neurourol Urodyn. 2018 01; 37(1):440-448.
Score: 0.090
-
A randomized, controlled clinical trial of a novel intravesical pressure attenuation device for the treatment of stress urinary incontinence. J Urol. 2013 Dec; 190(6):2243-50.
Score: 0.066
-
Does urinary urgency drive urinary frequency in overactive bladder? Low Urin Tract Symptoms. 2022 Jul; 14(4):242-247.
Score: 0.030
-
Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study. Low Urin Tract Symptoms. 2021 Oct; 13(4):425-434.
Score: 0.029
-
Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE). Adv Ther. 2019 08; 36(8):1906-1921.
Score: 0.025
-
Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder. J Urol. 2019 03; 201(3):573-580.
Score: 0.025
-
Study design and outcomes measures: The influence of composite endpoints and other design variables on outcomes in a study of a novel device for stress urinary incontinence. Neurourol Urodyn. 2018 11; 37(8):2919-2927.
Score: 0.024
-
Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon. Female Pelvic Med Reconstr Surg. 2018 May/Jun; 24(3):222-231.
Score: 0.023
-
Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically. Urology. 2009 Oct; 74(4):771-5.
Score: 0.013
-
A new questionnaire for urinary incontinence diagnosis in women: development and testing. Am J Obstet Gynecol. 2005 Jan; 192(1):66-73.
Score: 0.009